CUE-101, a Novel HPV16 E7-pHLA-Il-2-Fc Fusion Protein, Enhances Tumor Antigen Specific T Cell Activation for the Treatment of HPV16-Driven Malignancies

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-19-3354

Related search